Join
Live feed
·
PRReleasevia Quantisnow
Kura Oncology Inc. logo

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

ByQuantisnow·Wall Street's wire, on your screen.
KURA· Kura Oncology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KURA (Kura Oncology Inc.) and more on Quantisnow.